Citigroup’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Sell |
-58,529
| Closed | -$174K | – | 5089 |
|
2016
Q3 | $174K | Buy |
58,529
+53,968
| +1,183% | +$160K | ﹤0.01% | 3064 |
|
2016
Q2 | $6K | Sell |
4,561
-35,168
| -89% | -$46.3K | ﹤0.01% | 4680 |
|
2016
Q1 | $147K | Buy |
39,729
+8,997
| +29% | +$33.3K | ﹤0.01% | 3710 |
|
2015
Q4 | $310K | Sell |
30,732
-5,198
| -14% | -$52.4K | ﹤0.01% | 2721 |
|
2015
Q3 | $488K | Buy |
35,930
+27,204
| +312% | +$369K | ﹤0.01% | 2228 |
|
2015
Q2 | $166K | Buy |
8,726
+185
| +2% | +$3.52K | ﹤0.01% | 2879 |
|
2015
Q1 | $223K | Sell |
8,541
-3,688
| -30% | -$96.3K | ﹤0.01% | 2871 |
|
2014
Q4 | $257K | Buy |
12,229
+10,225
| +510% | +$215K | ﹤0.01% | 2974 |
|
2014
Q3 | $67K | Sell |
2,004
-5,388
| -73% | -$180K | ﹤0.01% | 3459 |
|
2014
Q2 | $237K | Sell |
7,392
-7,221
| -49% | -$232K | ﹤0.01% | 2465 |
|
2014
Q1 | $674K | Sell |
14,613
-1,456
| -9% | -$67.2K | ﹤0.01% | 1865 |
|
2013
Q4 | $1.14M | Buy |
16,069
+7,459
| +87% | +$530K | ﹤0.01% | 1749 |
|
2013
Q3 | $738K | Buy |
8,610
+5,804
| +207% | +$497K | ﹤0.01% | 1717 |
|
2013
Q2 | $178K | Buy |
+2,806
| New | +$178K | ﹤0.01% | 2832 |
|